Study Supports CyberKnife's Clinical Flexibility, Expanding Physicians Options for the Treatment of Prostate Cancer SUNNYVALE, Calif., April 8, 2008 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that a study published in
SUNNYVALE, Calif., March 27 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its senior vice president and chief financial officer, Robert E. McNamara, is scheduled to present at the B.
More Than 5,000 Lung Cancer Patients Treated With CyberKnife System to Date SUNNYVALE, Calif., March 26 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that approximately 90 percent of CyberKnife centers worldwide are now
SUNNYVALE, Calif., March 12 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the company received the 2008 North American Medical Devices Product of the Year award, from global growth consulting company Frost &
SUNNYVALE, Calif., March 10 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its management is scheduled to present at the Citi Investment Research Small & Mid-Cap Conference at the Four Seasons Hotel in Las Vegas on
All-Purpose Units Rarely Utilized for Radiosurgical Treatments SUNNYVALE, Calif., March 6 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today results of an independent survey, which concluded that the CyberKnife(R) Robotic
Major Academic Center Expands Cancer Treatment Access to Local Community SUNNYVALE, Calif., March 3 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that St. Louis University Hospital has purchased a second CyberKnife(R)
Large Scale Study Results Presented in Prostate, Lung and Brain Tumor Treatment SUNNYVALE, Calif., Feb. 12 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced key clinical presentation highlights from the 7th Annual CyberKnife
Click here for PDF version of this release Fourth Consecutive Quarter of Record Revenue and Backlog SUNNYVALE, Calif., Jan. 30 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced financial results for the second quarter of
New Service Helps Customers to Treat More Patients SUNNYVALE, Calif., Jan. 24 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the company will begin offering a treatment planning service to new and existing
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
